| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/16/2000 | CN1244584A Chemotarix factor with immunocyte chemotaxis and hemopoinesis stimulating activity |
| 02/16/2000 | CN1244536A Angiogenesis inhibiting factor 1 and its derivative and application |
| 02/16/2000 | CN1244429A Hedgelog protein medicinal composition and its use |
| 02/16/2000 | CN1049431C Morpholine derivative and its use and medicinal prepration containing said derivatives |
| 02/16/2000 | CN1049357C Treatment of human viral infection by ds RNA combined with viral inhibitors |
| 02/16/2000 | CN1049356C Protein-containing aqueous solutions |
| 02/15/2000 | US6025500 Heterogeneous catalytic reductive amination between alanylproline and ethyl-2-oxo-4-phenylbutyrate |
| 02/15/2000 | US6025484 Protein D--an IgD-binding protein ofhaemophilus influenzae |
| 02/15/2000 | US6025480 Isolated nucleic acid molecules encoding P57KIP2 |
| 02/15/2000 | US6025477 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 02/15/2000 | US6025475 Antibody |
| 02/15/2000 | US6025474 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
| 02/15/2000 | US6025473 Nucleic acid which encodes a protein which can confer multidrug resistance on a drug sensitive mammalian cell when expressed in the cell and which is overexpressed in certain multidrug resistant cancer cell lines |
| 02/15/2000 | US6025472 N-substituted glycine derivatives as enzyme inhibitors |
| 02/15/2000 | US6025471 Diazaspiro, azepino and azabicyclo therapeutic peptides |
| 02/15/2000 | US6025469 Murine UCP3 polypeptides |
| 02/15/2000 | US6025468 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides |
| 02/15/2000 | US6025467 Parathyroid hormone derivatives and their use |
| 02/15/2000 | US6025466 With antitumor activity |
| 02/15/2000 | US6025465 Insulin-like growth factor binding protein (IGFBP-6) |
| 02/15/2000 | US6025464 Two new WD-40 proteins |
| 02/15/2000 | US6025391 Enteric-coated pharmaceutical compositions of mycophenolate |
| 02/15/2000 | US6025368 Method for treating the symptoms of chronic stress-related disorders using IGF |
| 02/15/2000 | US6025345 Inhibitors of NAALADase enzyme activity |
| 02/15/2000 | US6025344 Certain dioic acid derivatives useful as NAALADase inhibitors |
| 02/15/2000 | US6025340 Surface expression of enzyme in gene directed prodrug therapy |
| 02/15/2000 | US6025339 Oligo is antisense to the initiation codon, the coding region or the 5' and 3' intronexon junctions of a gene encoding the adenosine a.sub.1 receptor or antisense to an adenosine a.sub.1 receptor mrna; and |
| 02/15/2000 | US6025334 Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof |
| 02/15/2000 | US6025333 Treatment of CNS tumors with metalloprotease inhibitors |
| 02/15/2000 | US6025332 Method for treating low circulating levels of sex hormone steroids associated with aging using IGF or IGF/IGFBP-3 |
| 02/15/2000 | US6025331 Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis |
| 02/15/2000 | US6025330 Inhibitors of fibrin cross-linking and/or transglutaminases |
| 02/15/2000 | US6025329 Method for treating ophthalmic diseases |
| 02/15/2000 | US6025328 Antitumor agents |
| 02/15/2000 | US6025327 Derived from chicken sternal cartilage; treating cartilage defects; nutritional supplement |
| 02/15/2000 | US6025326 Compositions and methods for the prevention and treatment of oral mucositis |
| 02/15/2000 | US6025325 Pegylated obese (ob) protein compositions |
| 02/15/2000 | US6025324 Pegylated obese (ob) protein compositions |
| 02/15/2000 | US6025204 Diagnostic method for detection of placental-derived prostate growth factors |
| 02/15/2000 | US6025198 Antisense modulation of Ship-2 expression |
| 02/15/2000 | US6025197 Secreted salivary zsig32 polypeptides |
| 02/15/2000 | US6025196 Chimeric proteins comprising liver enriched transcription factors and nucleic acids encoding the same |
| 02/15/2000 | US6025193 Dna construct of promoter, antisense oligonucleotide which binds to messenger rna in the translational start site region encoding the receptor, and a polyadenylation signal sequence; for improved selectivity in treatment |
| 02/15/2000 | US6025191 For diagnosis, immunotherapy, gene therapy and anticarcinogenic agents |
| 02/15/2000 | US6025180 Asp1 |
| 02/15/2000 | US6025176 For diagnosis and monitoring of insulin dependent diabetes mellitis; antidiabetic agents |
| 02/15/2000 | US6025175 Amino acid sequence; for screening new bactericides and bacteristats to treat otitis media, conjunctivitis, pneumonia, bacteremia, meningitis, sinusitis, pleural empyema and endocarditis; diagnosis of infections |
| 02/15/2000 | US6025166 Human trk receptors and neurotrophic factor inhibitors |
| 02/15/2000 | US6025163 DNA coding for a peptide of a papilloma virus main capside protein and use thereof |
| 02/15/2000 | US6025162 Nucleic acid encoding an amino acid sequence of protein; for diagnosis and treatment of allergies |
| 02/15/2000 | US6025157 Neurturin receptor |
| 02/15/2000 | US6025156 Amino acid sequence; for discovery of antibiotics, bactericides, bacteristats against staphylococcus infections |
| 02/15/2000 | US6025155 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
| 02/15/2000 | US6025154 Amino acid sequence; for anticarcinogenic/antitumor agents, wound healing agents; parasiticides; antiinflammatory/ antiarthritic agents; treatment of autoimmune diseases, allergic reactions, shock, chronic infections, psoriasis |
| 02/15/2000 | US6025151 Administering compounds to treat a non-swine subject for elevated platelet derived growth factor levels, jun kinase, c-jun or inflammatory cytokines, or activation of nf-kappab or nf-kappab p65 or neutrophil infiltration |
| 02/15/2000 | US6025150 Methods and compositions for wound healing |
| 02/15/2000 | US6025147 Inhibitors of interleukin-1 β converting enzyme |
| 02/15/2000 | US6025145 Sensitive, reliable immunoassay using eukaryotic cells expressing receptor construct comprising flag polypeptide and tyrosine kinase receptor, exposing to ligand, lysing cells and measuring phosphotyrosine |
| 02/15/2000 | US6025144 Immunoassay test kit for measuring bone resorption |
| 02/15/2000 | US6025143 Purified monoclonal or polyclonal antibody against a peptide having specific amino acid sequence from a gene controlled by andogens and isolated from submaxillary gland of the rat; for diagnosis, detection and therapeutics |
| 02/15/2000 | US6025142 Hydrophobic u-PAR binding site |
| 02/15/2000 | US6025141 Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form |
| 02/15/2000 | US6025140 Membrane-permeable constructs for transport across a lipid membrane |
| 02/15/2000 | US6025137 Exposing test sample under high stringency conditions to an isolated nucleic acid that hybridizes to fohy030 messenger rna; rna is from gene which is expressed at a higher level in benign, non-metastatic tumors than in malignant tumors |
| 02/15/2000 | US6025130 Nucleotide sequence of gene; for screening of homozygotes, diagnosis, and prenatal screening using oligonucleotide primers |
| 02/15/2000 | US6024983 Potentiating immunology biocompatible excipients in microcapsules |
| 02/15/2000 | US6024978 Oral drug composition with lipophilic compounds |
| 02/15/2000 | US6024961 Recombinant avirulent immunogenic S typhi having rpos positive phenotype |
| 02/15/2000 | US6024957 Immunomodulators and methods for the prevention and reversal of organ transplant rejection using same |
| 02/15/2000 | US6024936 Antibody-based method of localizing activated thrombin receptors |
| 02/15/2000 | US6024734 Treatment methods using homeopathic preparations of growth factors |
| 02/15/2000 | US6024688 Angiostatin fragments and method of use |
| 02/15/2000 | US6024090 Method of treating a diabetic patient by aerosolized administration of insulin lispro |
| 02/15/2000 | CA2168552C Refolding of polypeptides like recombinant insulin-like growth factor igf-1 |
| 02/15/2000 | CA2132001C Methods of treating cancer using modified c-reactive protein |
| 02/15/2000 | CA2093667C Mouse monoclonal antibodies and uses thereof |
| 02/15/2000 | CA2077461C Inhibition of the formation or activity of human leukocyte 12-lipoxygenase pathway |
| 02/15/2000 | CA2015994C Human lactoferrin cdna sequence |
| 02/15/2000 | CA2006008C Method for making synthetic oligonucleotides which bind specifically to target sites on duplex dna molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use |
| 02/15/2000 | CA2005300C Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus |
| 02/15/2000 | CA1340898C Monoclonal antibodies against lymphoma-associated antigens, hybrid cell lines producing these antibodies, and use therefore |
| 02/14/2000 | CA2280061A1 Method of prevention and treatment of multiple sclerosis with varicella zoster immune globulin |
| 02/14/2000 | CA2245224A1 Chemokine receptor antagonists and chemotherapeutics |
| 02/12/2000 | CA2248989A1 Novel compounds |
| 02/11/2000 | CA2280241A1 Method of producing iron-whey-proteolysate complex |
| 02/10/2000 | WO2000007014A2 Leptin-mediated gene-induction |
| 02/10/2000 | WO2000006775A1 Exon deletion antisense drug design and therapy |
| 02/10/2000 | WO2000006759A2 Anti-angiogenesis plasmids and delivery systems, and methods of making and using the same |
| 02/10/2000 | WO2000006758A1 Self-deleting vectors for cancer therapy |
| 02/10/2000 | WO2000006745A1 Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine |
| 02/10/2000 | WO2000006744A1 Granulocytic ehrlichia genes and uses thereof |
| 02/10/2000 | WO2000006743A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006742A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006735A1 Interferon alpha hybrids |
| 02/10/2000 | WO2000006734A1 Chondrogenic and osteogenic inducing molecule |
| 02/10/2000 | WO2000006733A2 T cell receptor proteins, nucleic acid molecules, and uses thereof |
| 02/10/2000 | WO2000006732A2 Polynucleotide encoding an autoantigen associated with endometriosis |
| 02/10/2000 | WO2000006731A2 PERSEPHIN ARF, A PROTEIN ENCODED BY UNSPLICED PERSEPHIN mRNA |
| 02/10/2000 | WO2000006730A2 Human cytoskeletal proteins |
| 02/10/2000 | WO2000006729A1 Kdel receptor inhibitors |